Colorectal cancer originates from colorectal polyps. INOGENIX's blood-based colorectal cancer screening test is the world's only test that diagnoses both colorectal polyps and colorectal cancer with a sensitivity of over 90%. Based on this technology, INOGENIX was selected as the first biotech company for 'Deep Tech TIPS' in 2023 and is currently targeting global markets including the United States and Canada, with the goal of advancing as a global company.